The Shkreli Pill

In this episode, Martin introduces a trading strategy designed to compound small statistical advantages across multiple trades rather than relying on a few large wins. He discusses position sizing, probability, risk management, and how incremental edges can contribute to long-term performance. Martin also analyzes Intel and Tenax Therapeutics (TENX), sharing his perspective on their valuations, ri...

In this episode, Martin discusses the departure of a leading AI researcher from Google and what the emergence of another ambitious AI venture could mean for the competitive landscape. He also expands on his thesis that increasingly capable AI models and agents could disrupt traditional software companies, examining the potential impact on SaaS business models, competitive moats, pricing power, and...

This compilation brings together Martin’s discussions on how the opportunities for building wealth in financial markets have evolved over time. Across a range of clips, he examines the limitations of trading alone and explores the importance of investing, business ownership, capital allocation, and developing a durable edge. He also shares lessons on risk, compounding, market efficiency, and where...

In this episode, Martin discusses how Apple's strategy could affect Micron and the broader memory semiconductor market. He also examines the competitive pressures facing Adobe as artificial intelligence reshapes the software industry and revisits his short thesis on SanDisk, explaining why he believes the trade could become increasingly volatile and the key risks and catalysts investors should...

In this episode, Martin discusses why he believes the semiconductor cycle may be approaching a turning point and examines the risks facing the sector. He also explains how to construct a hedged portfolio, including balancing long and short positions, managing exposure, and controlling risk. Martin then revisits SanDisk and Tenax Therapeutics (TENX), outlining the factors shaping his current invest...

In this episode, Martin compares his trading performance with that of his intern and examines the strategies and decisions contributing to the intern’s results. He shares practical trading insights on position sizing, risk management, and identifying opportunities, while walking through a live portfolio breakdown and explaining the reasoning behind current positions, recent trades, and potential o...

In this episode, Martin breaks down how his intern generated a $5,000 trading profit using just three stocks, examining the decisions, position sizing, and strategy behind the trades. He uses the results to discuss broader lessons on developing trading skills, managing risk, and concentrating on high-conviction opportunities. Martin also revisits Tenax Therapeutics, outlining his short thesis and...

In this episode, Martin sits down with the team for a wide-ranging discussion on artificial intelligence, the memory semiconductor cycle, and the future of SaaS businesses. He also shares his perspective on Palantir and the competitive pressures facing software companies, while discussing trading strategy, market cycles, risk management, and the investment themes he believes are most important to...

In this episode, Martin explains why he increased his position in Google and discusses the developments that strengthened his investment thesis. He also analyzes Eli Lilly and Intel, shares his bearish outlook on selected quantum computing stocks, and revisits Tenax Therapeutics, examining its clinical prospects, valuation, and the factors influencing his current investment outlook.

In this episode, Martin mentors a young intern on the fundamentals of becoming a successful trader, focusing on the principles he believes matter most for long-term success. He discusses trade selection, risk management, position sizing, market psychology, and the importance of discipline, explaining how to develop a repeatable investment process while avoiding common mistakes made by inexperience...

In this episode, Martin mentors a young intern on the fundamentals of becoming a successful trader, focusing on the principles he believes matter most for long-term success. He discusses trade selection, risk management, position sizing, market psychology, and the importance of discipline, explaining how to develop a repeatable investment process while avoiding common mistakes made by inexperience...

In this episode, Martin discusses Anthropic's latest AI developments and their potential implications for Nvidia's position in the AI hardware ecosystem. He also examines Intel's artificial intelligence strategy, reviews SanDisk's latest earnings results, and analyzes Tenax Therapeutics (TENX), sharing his perspective on each company's competitive position, valuation, and the f...

In this episode, Martin discusses the recent move in AMD's stock price and examines the factors he believes are driving investor sentiment. He also shares his perspective on Nvidia's role in AI infrastructure, comments on SpaceX's GPU-related strategy, and reviews the latest clinical trial developments at Tenax Therapeutics (TENX), discussing their potential implications for the compan...

In this episode, Martin discusses why he believes Palantir could face the same long-term competitive pressures affecting the broader software industry as artificial intelligence continues to evolve. He explains the reasoning behind his outlook for enterprise software, then analyzes Intel and Tenax Therapeutics (TENX), examining their businesses, valuations, competitive positions, and the key facto...

In this episode, Martin discusses his view that advances in artificial intelligence could dramatically reshape the software industry over the next several years. He explains why he believes many traditional software companies may face increasing competitive pressure from AI-driven products and automation, examining the potential impact on business models, margins, valuations, and long-term investm...

In this episode, Martin explains why he believes making smaller, disciplined bets can lead to better long-term trading performance. He discusses position sizing, risk management, expected returns, and the psychological benefits of limiting exposure, while outlining how consistent capital preservation and disciplined decision-making can improve investment outcomes over time.

In this episode, Martin explains the core principles behind his trading strategy, including how he incorporates technical analysis alongside fundamental research to identify trading opportunities and manage risk. He discusses chart patterns, timing, and position management before sharing his views on Tenax Therapeutics and Amazon, analyzing their businesses, valuations, and the factors influencing...

In this episode, Martin reflects on a short position in Palantir that moved against him and discusses the lessons he learned from the trade. He also examines whether Anthropic's advances in artificial intelligence could pose a competitive threat to Palantir's business, analyzing the companies' strategies, competitive positioning, and the broader impact of AI on enterprise software and...

This compilation brings together Martin’s discussions on capital allocation, active investing, and market cycles. Across a range of clips, he explains why he believes actively deploying capital into high-conviction opportunities can outperform passive investing during periods of market excess and subsequent corrections. The episode also covers portfolio management, valuation, risk control, and the...

In this episode, Martin discusses adding to one of his investment positions and explains the reasoning behind increasing his exposure. He also analyzes Bloom Energy, Adicet Bio, Google, and Thermo Fisher Scientific (TMO), examining each company's business, competitive position, valuation, and long-term prospects while sharing the factors that shape his current investment outlook.

In this episode, Martin discusses receiving another margin call and explains how market volatility and leveraged positions can affect portfolio management. He also shares his perspective on Micron's recent decline, analyzes Amazon and Nebius, and reviews a clinical trial involving Tenax Therapeutics, discussing the implications for the company and the factors influencing his investment outlook...

In this episode, Martin shares his outlook for the broader market and discusses the trends he believes investors should watch in the coming months. He also explains why he views Meta as an attractive investment opportunity and introduces the Kelly Criterion, outlining how the framework can be used to determine position sizes and allocate capital more effectively while balancing expected returns an...

In this episode, Martin reflects on a short position in Amazon that moved against him and discusses the lessons he took away from the trade. He also explains why he believes Meta may represent an attractive buying opportunity, shares his views on Reddit and Nvidia, and revisits his bearish thesis on SanDisk, examining each company's valuation, competitive position, and the factors influencing...

In this episode, Martin discusses the market events surrounding Leopold Aschenbrenner's reported liquidation and explains how he believes Ken Griffin and Citadel became involved in absorbing or trading the affected positions. He examines market structure, institutional trading, liquidity, and risk management, sharing his perspective on how large firms respond to forced liquidations and the les...

In this episode, Martin discusses receiving a margin call from JPMorgan following market events related to Leopold Aschenbrenner's reported liquidation. He explains how leverage, margin requirements, and counterparty risk can affect investors during periods of heightened volatility, while sharing his perspective on risk management, portfolio construction, and the lessons traders can learn from...